Healthcare AI: SOPHiA GENETICS growth

Today's strongest new evidence comes from healthcare AI. SOPHiA GENETICS announced 27 per cent year-on-year quarterly revenue growth, 115,000 platform analyses and raised full-year guidance, and separately announced two companion-diagnostic programmes with AstraZeneca. The financial figures are supported by a Form 6-K filing; clinical benefit remains prospective, and products may not be approved in some jurisdictions, the company warns.

The White House's voluntary advanced-model cyber-testing framework moved to industry review. NASA's Space Roboticist Challenge held a technical mission briefing for prospective in-orbit experiments, and the Black Hat AI Summit focused on agentic security and GPU and cloud protection. Within 72 hours, Alibaba's Qwen3.8-Max, DeepSeek's V4-Flash, Onsemi's AI data-centre outlook and the EU AI Act enforcement milestone were also significant.